drugset / Trial / NCT01440751

Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery

NCT01440751

RandomizedParallel-groupOpen-labelPrevention

Summary

The objective of this prospective randomised study is to compare the efficacy and safety of ologen CM (Collagen matrix) and Mitomycin-C (MMC) as adjuncts to filtration surgery in uncontrolled treated glaucoma cases, the efficacy being the primary objective and the safety being the secondary.

Timeline

Start
2011-09
Primary completion
2013-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mitomycin C Other / unclassified 15 ug Topical
Comparator Mitomycin C Other / unclassified 0.4 mg/ml Topical

Indications